# Apparent diffusion coefficient can assist in differentiating between benign and malignant primary bone tumors in pediatric patients

**Authors:** Yashas Ullas Lokesha, Shashi Bhushan Singh, Ricarda von Krüchten, Zahra Shokri Varniab, Manoj Kumar, Vidyani Suryadevara, Amir Hossein Sarrami, Tie Liang, Jason Wong, Allison Pribnow, Heike Elisabeth Daldrup-Link

PMC · DOI: 10.1007/s00256-025-05060-8 · Skeletal Radiology · 2025-10-29

## TL;DR

This study shows that apparent diffusion coefficient values from MRI scans can help distinguish between benign and malignant bone tumors in children.

## Contribution

The study demonstrates that ADCmean provides the highest diagnostic accuracy for differentiating benign and malignant pediatric bone tumors.

## Key findings

- Benign tumors had significantly higher ADCmean, ADCmin, and ADCmax values compared to malignant tumors.
- ADCmean had the highest diagnostic accuracy with a sensitivity of 77% and specificity of 93%.
- ADCmin and ADCmax also showed diagnostic potential but with lower accuracy than ADCmean.

## Abstract

To evaluate differences in apparent diffusion coefficient (ADC) values between benign and malignant primary pediatric bone tumors and to assess their diagnostic accuracy in differentiating these tumors.

We retrospectively analyzed MRI scans of 96 pediatric patients (54 males, 42 females; mean age 12.97 ± 3.9 years) with primary bone tumors who underwent diffusion-weighted imaging, including 48 benign and 48 malignant tumors. We measured ADCmean, ADCmin, and ADCmax of the solid tumor part, carefully avoiding cystic, necrotic, or sclerosed tumor areas. The Wilcoxon rank-sum test was used to test the distributional difference of benign vs malignant tumors. ROC curve analysis was performed to assess the diagnostic accuracy. The optimal cutoff of ADC values to differentiate benign and malignant bone tumors was defined as the point at which the Youden index, the sum of sensitivity and specificity, was maximized.

The median values of the ADCmean, ADCmin, and ADCmax for benign bone tumors [1.34 (1.13–1.83), 0.98 (0.73–1.34), and 1.80 (1.57–2.46) × 10−3mm2/s, respectively] were significantly higher compared to malignant bone tumors [0.93 (0.78–1.03), 0.59 (0.43–0.72), and 1.35 (1.22–1.66) × 10−3mm2/s, respectively; all p < 0.05]. ADCmean yielded the highest diagnostic accuracy, with an optimal cutoff of 1.04 (0.94–1.15) × 10−3mm2/s (sensitivity 77%, specificity 93%, AUC = 0.91). An ADCmin cutoff of 0.82 (0.65–0.98) × 10−3mm2/s resulted in a sensitivity of 87.5%, specificity of 70.0%, and AUC of 0.85. An ADCmax cutoff of 1.48 (1.18–1.78) × 10−3mm2/s achieved a sensitivity of 68%, specificity of 81%, and AUC of 0.80.

ADCmean, ADCmin, and ADCmax differ significantly between benign and malignant pediatric bone tumors, and the ADCmean provides the highest diagnostic accuracy.

The online version contains supplementary material available at 10.1007/s00256-025-05060-8.

## Linked entities

- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** tumor (MESH:D009369), bone tumors (MESH:D001859), necrotic (MESH:D009336)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12847184/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12847184/full.md

---
Source: https://tomesphere.com/paper/PMC12847184